Related Experiment Videos
Dermatological toxicity of ixabepilone
Alison K Conlin1, Linda Vahdat
1Division of Oncology, Department of Internal Medicine, New York-Presbyterian Weill Cornell Medical Center, New York, NY, USA.
Abstract:
Ixabepilone is a new class of non-taxane microtubule-stabilizing agents. These agents bind tubulin, stabilize microtubules and, thus, block mitosis and result in cell death (1-8). In phase I studies, neutropenia was the only grade 4 toxicity while fatigue, anorexia and mucositis occurred as grade 3 toxicities. Neuropathy, myalgia, arthralgia, alopecia and gastro-intestginal toxicities also occurred at grades 1 and 2. No dermatological effects have been documented to date. Here, a case is reported of a 62-year-old woman with stage 4 breast cancer being treated with Ixabepilone (40 mg/m2) who developed a dermatological reaction not previously described as a toxicity from Ixabepilone therapy.
Insights
Ixabepilone, a microtubule-stabilizing agent, is used for breast cancer. A patient developed an unexpected skin reaction, highlighting a previously undocumented toxicity of this chemotherapy.
Area of Science:
- Oncology
- Pharmacology
Background:
- Ixabepilone is a novel non-taxane microtubule-stabilizing agent.
- It functions by binding tubulin, stabilizing microtubules, inhibiting mitosis, and inducing cancer cell death.
- Previous Phase I studies documented neutropenia, fatigue, anorexia, mucositis, neuropathy, myalgia, arthralgia, alopecia, and gastrointestinal toxicities.
Observation:
- A case report details a 62-year-old woman with stage 4 breast cancer undergoing Ixabepilone treatment (40 mg/m2).
- The patient experienced a dermatological reaction.
- This reaction was not previously documented as a toxicity associated with Ixabepilone therapy.
Findings:
- The study reports a novel dermatological adverse event associated with Ixabepilone.
- This finding expands the known toxicity profile of Ixabepilone.
Implications:
- This case highlights the importance of monitoring for and reporting rare adverse events.
- It may necessitate updates to the known side effect profile of Ixabepilone.
- Further investigation into Ixabepilone's dermatological toxicities is warranted.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Frequency-dependent Selection
Predator-Prey Interactions
Responses to Salt Stress
Comparative Excretory Systems
The Stanford Prison Experiment